申请人:Pharmacia Aktiebolag
公开号:US05574031A1
公开(公告)日:1996-11-12
Compounds of general formula (I) are useful for treating mental disorders, wherein R.sub.1 and R.sub.2 are the same or different and selected from hydrogen or lower alkyl; Ar are the same or different and selected from pyridyl and phenyl groups, n is 1 or 2, X is nitrogen or methine. When X is nitrogen, Y is methylene. When X is methine, Y is selected from nitrogen or oxygen. A is selected from carboxylic derivatives. The pharmacologically active salts of formula (I) are also embraced. ##STR1##
通式(I)的化合物对治疗精神障碍有用,其中R.sub.1和R.sub.2相同或不同,选自氢或较低的烷基;Ar相同或不同,选自吡啶基和苯基,n为1或2,X为氮或甲烷基。当X为氮时,Y为亚甲基。当X为甲烷时,Y选自氮或氧。A选自羧酸衍生物。通式(I)的药理活性盐也包括在内。